Advertisement
Advertisement

PTGX

PTGX logo

Protagonist Therapeutics, Inc

100.39
USD
Sponsored
+1.87
+1.90%
Mar 24, 15:59 UTC -4
Closed
exchange

Pre-Market

100.41

+0.02
+0.02%

Protagonist Therapeutics, Inc Financial Snapshot

Market Cap
6.41B
Beta
2.23
Earnings Per Share (EPS)
-2.05
Price-to-Book (P/B) Ratio
10.06
Operating Margin
-282.83%
Total Debt/Equity (D/E)
0.00%
P/E Ratio
--
Return on Equity (ROE)
-19.89%
Current Ratio
12.71%
Free Cash Flow
56.08M

Earnings Chart

Advertisement